Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Res Commun Mol Pathol Pharmacol ; 95(3): 343-6, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9144840

ABSTRACT

The aim of this study was to investigate the cytoprotective effect of Iloprost on the liver against carbon tetrachloride induced necrosis. The serum histamine-like activity was found to be increased when compared with that of controls after treatment with carbon tetrachloride for 18 weeks while prostaglandin E2- and leukotriene C4-like activities were unchanged. After pretreatment with Iloprost for 18 weeks the increased activity of histamine was found to be unchanged while prostaglandin E2-like activity was increased. It is concluded that Iloprost protects the liver against carbon tetrachloride-induced damage and reduces the level of histamine that has a role in the pathogenesis of portal hypertension.


Subject(s)
Carbon Tetrachloride/toxicity , Iloprost/therapeutic use , Liver Cirrhosis, Experimental/drug therapy , Platelet Aggregation Inhibitors/therapeutic use , Vasodilator Agents/therapeutic use , Animals , Carbon Tetrachloride/administration & dosage , Dinoprostone/blood , Disease Models, Animal , Female , Histamine/blood , Hypertension, Portal/drug therapy , Hypertension, Portal/prevention & control , Iloprost/administration & dosage , Iloprost/pharmacology , Injections, Subcutaneous , Leukotriene C4/blood , Liver/cytology , Liver/drug effects , Liver/pathology , Liver Cirrhosis, Experimental/chemically induced , Liver Cirrhosis, Experimental/prevention & control , Male , Platelet Aggregation Inhibitors/administration & dosage , Platelet Aggregation Inhibitors/pharmacology , Rats , Vasodilator Agents/administration & dosage , Vasodilator Agents/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...